Covid-19 Under Democracy and Autocracy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Procedural Digest 24 25 26 27 28
HOUSE OF REPRESENTATIVES August/ September 2020 M T W T F Procedural Digest 24 25 26 27 28 No. 12 31 1 2 3 4 46th Parliament 24 August – 3 September 2020 Selected entries contain links to video footage via Parlview. Please note that the first time you click a [Watch] link, you may need to refresh the page (ctrl+F5) for the correct starting point. Bills 12.01 Jobkeeper bill introduced and passed all stages in one sitting The Treasurer presented the Coronavirus Economic Response Package (Jobkeeper Payments) Amendment Bill 2020 on 26 August. In his second reading speech, the Treasurer thanked the opposition for its support in progressing the bill through the parliament quickly to provide certainty to Australian businesses and employees. Following his speech, the House gave leave for the debate to be made an order of the day for a later hour. During the day, 28 members contributed to the second reading debate. At the conclusion of the debate, a second reading amendment moved by the shadow Treasurer was negatived on division and the question ‘that the bill be read a second time’ was carried on the voices. Following a message from the Governor-General recommending appropriation, the bill proceeded to the consideration in detail stage and several opposition amendments were negatived on division. Consideration in detail concluded and, by leave, an assistant minister moved the third reading. The question ‘that the bill be read a third time’ was carried on the voices. The Speaker granted the Manager of Opposition Business indulgence a number of times over the sitting fortnight to place on the record the voting intentions of independent and minor party members unable to attend the sittings due to the pandemic. -
Brazil's Ascendance: the Soft Power Role of Global Health Diplomacy
Brazil’s Ascendance: The soft power role of global health diplomacy By Kelley Lee and Eduardo J. Gómez Introduction Brazil’s steady ascendance on the world stage over the past decade has been led, in large part, by the country’s growing economic might. A much lauded BRIC (Brazil, Russia, India and China) country blessed by vast resources, Brazil is predicted to emerge this century as a regional and global economic powerhouse. However, the country’s rising influence must also be understood as the product of an effective foreign policy and, in particular, the assumption of high-profile diplomatic roles in negotiating to address key global issues such as climate change, nuclear non-proliferation and trade liberalisation. Among emerging economies, Brazil has been particularly adept at leveraging what is de- scribed as “soft power”, defined as the capac- ity to persuade or attract others to do what one wants through the force of ideas, knowl- edge and values. Coined by Joseph Nye, the concept of soft power contrasts with “hard power” whereby coercion (underpinned by years, world leaders have begun to talk about advocates the use of health care as an instru- military and economic might) is used to in- “smart power” whereby soft and hard power ment for furthering foreign policy goals. As fluence others to act in ways in which they is combined in ways that are mutually rein- then US Secretary of State for Health Tommy would not otherwise do. He argues that, in forcing.1 Brazil’s prominence in global health Thompson stated in 2004, as part of the Bush a more interconnected world of accelerating diplomacy can be understood in this con- Administration’s efforts to rebuild its global globalisation and resultant collective action text. -
The Tocsin | Issue 12, 2021
Contents The Tocsin | Issue 12, 2021 Editorial – Shireen Morris and Nick Dyrenfurth | 3 Deborah O’Neill – The American Warning | 4 Kimberley Kitching – Super Challenges | 7 Kristina Keneally – Words left unspoken | 10 Julia Fox – ‘Gender equality is important but …’ | 12 In case you missed it ... | 14 Clare O’Neil – Digital Dystopia? | 16 Amanda Rishworth – Childcare is the mother and father of future productivity gains | 18 Shireen Morris – Technology, Inequality and Democratic Decline | 20 Robynne Murphy – How women took on a giant and won | 24 Shannon Threlfall-Clarke – Front of mind | 26 The Tocsin, Flagship Publication of the John Curtin Research Centre. Issue 12, 2021. Copyright © 2021 All rights reserved. Editor: Nick Dyrenfurth | [email protected] www.curtinrc.org www.facebook.com/curtinrc/ twitter.com/curtin_rc Editorial Executive Director, Dr Nick Dyrenfurth Committee of Management member, Dr Shireen Morris It was the late, trailblazing former Labor MP and Cabinet Minister, Susan Ryan, who coined the memorable slogan ‘A must be identified and addressed proactively. We need more Woman’s Place is in the Senate’. In 1983, Ryan along with talented female candidates being preselected in winnable seats. Ros Kelly were among just four Labor women in the House of We need more female brains leading in policy development Representatives, together with Joan Child and Elaine Darling. and party reform, beyond the prominent voices on the front As the ABC notes, federal Labor boasts more than double the bench. We need to nurture new female talent, particularly number of women in Parliament and about twice the number women from working-class and migrants backgrounds. -
GAZİANTEP UNIVERSITY JOURNAL of SOCIAL SCIENCES 'Pandemic
GAZİANTEP UNIVERSITY JOURNAL OF SOCIAL SCIENCES 2020 SPECIAL ISSUE 413-428 GAZİANTEP UNIVERSITY JOURNAL OF SOCIAL SCIENCES Journal homepage: http://dergipark.org.tr/tr/pub/jss Araştırma Makalesi ● Research Article ‘Pandemic Diplomacy’ and the Politics of Paradox: International Cooperation in the Age of National Distancing ‘Pandemik Diplomasi’ ve Paradoks Politikası: Ulusal Mesafe Çağında Uluslararası İşbirliği Wasiu A. BALOGUNa*, Oluwaseun I. SOILEb a PhD, Lancaster University, Lancaster / UNITED KINGDOM ORCID ID: 0000-0001-8519-2053 b Researcher, Olabisi Onabanjo University, Ago-Iwoye / NIGERIA ORCID ID: 0000-0002-0047-1684 M A K A L E B İ L G İ S İ Ö Z Makale Geçmişi: Soğuk Savaş'ın sona ermesinden bu yana hiçbir gelişme uluslararası siyasi sistemi COVID-19 salgını kadar etkilememiştir. Bir sağlık krizi uluslararası siyaseti yeniden şekillendiriyor, küresel ekonomiyi baltalıyor, Başvuru tarihi: 14 Ağustos 2020 küresel iklim değişikliği görüşmelerini baltalıyor ve diplomasi için birçok yeni sorun yaratıyor. Paradoksal Kabul tarihi: 15 Ekim 2020 olarak, dünya, uluslararası seyahat yasaklarının, sınır kapatmaların ve ulusal mesafenin olduğu bir zamanda, bir hastalıkla mücadele için, bir araya geliyor. Başka bir boyutta, milliyetçilik uluslararası iş birliğinin umut sunduğu küresel salgın zamanında enternasyonalizmi gölgede bırakıyor. Salgın, birçok zorluk göz önüne Anahtar Kelimeler: alındığında uluslararası siyaset ve diplomasinin yeni bir düzeninin habercisi olsa da süper güç rekabetinin ve COVID-19, iş birliğinin eski düzenini sürdürmektedir. COVID-19 salgını çözülürken, siyasi ve diplomatik çelişkiler Diplomasi, devletler arası ilişkileri güçlendirmekte ve aşı geliştirme umutları ve COVID-19 sonrası dünya düzeninin doğası etrafında belirsizlikler yaratmaktadır. Bu çalışma, COVID-19'un diplomatik uygulamalarını ve salgının Uluslararası iş birliği, patlak vermesinden bu yana küresel politika ve diplomasiyi nasıl şekillendirdiklerini sorgulamayı Milliyetçilik, amaçlamaktadır. -
The Critical Importance of Expert Statistical Input
Sent to the Department of the Prime Minister and Cabinet 18 August 2020 A proposal to enhance Australia’s capability to manage epidemics The critical importance of expert statistical input 1 2 Nicholas Fisher and Dennis Trewin Executive summary Given the high level of global mobility, pandemics are likely to be more frequent, and with potentially devastating consequences for the Australian community and its way of life. Whilst parts of Australia are experiencing a second wave of COVID-19, the country is in relatively better shape than most others. The number of people who have died or been seriously ill as a consequence of the virus, whilst tragically high, is nonetheless comparable with most of the best-performing countries. That said, we believe there is a critical need for strategic statistical oversight of the whole process of anticipating, managing and learning from the current pandemic to improve the quantitative information and advice provided to policy makers. This proposal outlines quantitative aspects of a plan to enable Australia to deal more efficiently and effectively with future such events, thus enhancing both the social and the economic welfare of its people. Indeed, expeditious action may well assist materially in managing possible future waves of the current pandemic, and its aftermath. A dispassionate assessment of Australia’s health and economic response to the pandemic over the last six months reveals some very significant inadequacies in the data, statistical analysis and interpretation used to guide Australia’s preparations and actions. Data to answer some of the most basic of questions about prevalence in population have not been available and remain unavailable. -
COVID-19 Vaccination Programme: Information for Healthcare Practitioners
COVID-19 vaccination programme Information for healthcare practitioners Republished 6 August 2021 Version 3.10 1 COVID-19 vaccination programme: Information for healthcare practitioners Document information This document was originally published provisionally, ahead of authorisation of any COVID-19 vaccine in the UK, to provide information to those involved in the COVID-19 national vaccination programme before it began in December 2020. Following authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency being given to the COVID-19 Vaccine Pfizer BioNTech on 2 December 2020, the COVID-19 Vaccine AstraZeneca on 30 December 2020 and the COVID-19 Vaccine Moderna on 8 January 2021, this document has been updated to provide specific information about the storage and preparation of these vaccines. Information about any other COVID-19 vaccines which are given regulatory approval will be added when this occurs. The information in this document was correct at time of publication. As COVID-19 is an evolving disease, much is still being learned about both the disease and the vaccines which have been developed to prevent it. For this reason, some information may change. Updates will be made to this document as new information becomes available. Please use the online version to ensure you are accessing the latest version. 2 COVID-19 vaccination programme: Information for healthcare practitioners Document revision information Version Details Date number 1.0 Document created 27 November 2020 2.0 Vaccine specific information about the COVID-19 mRNA 4 Vaccine BNT162b2 (Pfizer BioNTech) added December 2020 2.1 1. -
An Affront to Dignity, Inclusion and Equality: Coronavirus and the Impact of Law, Policy and Practice on People with Disabilities in the United Kingdom
Report Recommendations - An Affront to Dignity, Inclusion and Equality: Coronavirus and the impact of law, policy and practice on people with disabilities in the United Kingdom In the following areas our Report urges the government to: On reforming the Coronavirus Act 2020, disability rights and mitigating effects of the pandemic 1. Undertake an immediate review of legislation passed during the coronavirus crisis and communication thereof. In doing so, we ask that the government change this legislation and all related policymaking to meet its duties under the Equality Act 2010, and commitments to the United Nations Convention on the Rights of Persons with Disabilities, and take steps to avoid or mitigate any potential disadvantage for disabled people. 2. Implement recommendations made by the 2016 House of Lords Select Committee Report on the Equality Act 2010 and Disability, and by the Women and Equalities Committee, on enhancing the enforcement of the Equality Act 2010, both by removing deterrents to individuals bringing disability discrimination cases; and by measures which embed the monitoring and enforcement of relevant duties in the work of regulatory and inspection bodies. 3. Undertake an inquiry on the impact of COVID-19 on disabled people to examine why this group has carried such a heavy burden for the pandemic, including the scale of Covid-19 related deaths. 4. Establish a Covid-19 Disability Inclusive Response and Recovery Group, of experts by experience with disabilities and Disabled People’s Organisations, to ensure disabled people are central to decision-making on the economic and social recovery to the pandemic and guidance. 5. -
Reflections on Representation and Reform in the House of Lords
Our House: Reflections on Representation and Reform in the House of Lords Edited by Caroline Julian About ResPublica ResPublica is an independent, non-partisan UK think tank founded by Phillip Blond in November 2009. In July 2011, the ResPublica Trust was established as a not-for-profit entity which oversees all of ResPublica’s domestic work. We focus on developing practical solutions to enduring socio-economic and cultural problems of our time, such as poverty, asset inequality, family and social breakdown, and environmental degradation. ResPublica Essay Collections ResPublica’s work draws together some of the most exciting thinkers in the UK and internationally to explore the new polices and approaches that will create and deliver a new political settlement. Our network of contributors who advise on and inform our work include leaders from politics, business, civil society and academia. Through our publications, compendiums and website we encourage other thinkers, politicians and members of the public to join the debate and contribute to the development of forward-thinking and innovative ideas. We intend our essay collections to stimulate balanced debate around issues that are fundamental to our core principles. Contents Foreword by Professor John Milbank and Professor Simon Lee, Trustees, 1 The ResPublica Trust 1. Introduction 4 Caroline Julian, ResPublica 2. A Statement from the Government 9 Mark Harper MP, Minister for Political and Constitutional Reform A Social Purpose 3. A Truly Representative House of Lords 13 The Rt Hon Frank Field, MP for Birkenhead 4. Association and Civic Participation 16 Dr Adrian Pabst, University of Kent 5. Bicameralism & Representative Democracy: An International Perspective 23 Rafal Heydel-Mankoo 6. -
Jens Spahn Die Biografie ® MIX Papier Aus Verantwor- Tungsvollen Quellen
Michael Bröcker Jens Spahn Die Biografie ® MIX Papier aus verantwor- tungsvollen Quellen ® www.fsc.org FSC C083411 © Verlag Herder GmbH, Freiburg im Breisgau 2018 Alle Rechte vorbehalten www.herder.de Satz: Barbara Herrmann, Freiburg Herstellung: CPI books GmbH, Leck Printed in Germany ISBN Print: 978-3-451-38336-2 ISBN E-Book: 978-3-451-81676-5 Inhalt 1. Vorwort .......................................... 7 2. »Er ist mir zu schnell groß geworden« – Kindheit und Jugend in Ottenstein ................ 13 3. »Ahaus – ausgesprochen radioaktiv« – wie die Castor-Gegner Spahn politisierten ......... 27 4. »Wir haben ein Wowereit-Problem« – erste Kandidatur, erste Widerstände ............... 46 5. »Ich kenn’ Sie doch aus der ›Aktuellen Stunde‹« – der Hinterbänkler in Berlin ....................... 59 6. »So klug wie anrüchig« – ein Freundschaftsdienst mit Folgen ........................................ 76 7. »Jemand wie Sie gehört aufgehängt« – das Renten-Drama ................................ 81 8. »Der kann ja Fachpolitik« – Aufstieg zum Gesundheitsexperten und neue politische Freunde . 85 9. »Ein Mann wie eine Walze« – Spahn, sein Mann und das Problem mit den Schwulen ................... 91 10. »Der Clübchengründer« – der Schweiger wird zum Netzwerker .............. 108 11. »Bevor es der Armin macht« – der Rivale im eigenen Land ....................... 139 12. »Jetzt erst recht« – der Übergangene putscht sich ins Präsidium ..................................... 150 5 13. »Eine Art Staatsversagen« – Geburt eines Merkel-Kritikers ..................... 169 14. »Welcome Deputy Finance Minister« – Spahns mächtiger Förderer ........................ 189 15. »Dann ziehe ich dir den Stecker« – der Zwei-Minuten-Eklat beim Parteitag ........... 201 16. »Denen überlassen wir das Land nicht« – die Anti-Merkel-Troika ........................... 206 17. »Die Mitte ist rechts von uns« – ein alter Richtungsstreit und eine neue Rivalin .... 216 18. »Der muss schon loyal sein« – endlich Minister .. -
THE 422 Mps WHO BACKED the MOTION Conservative 1. Bim
THE 422 MPs WHO BACKED THE MOTION Conservative 1. Bim Afolami 2. Peter Aldous 3. Edward Argar 4. Victoria Atkins 5. Harriett Baldwin 6. Steve Barclay 7. Henry Bellingham 8. Guto Bebb 9. Richard Benyon 10. Paul Beresford 11. Peter Bottomley 12. Andrew Bowie 13. Karen Bradley 14. Steve Brine 15. James Brokenshire 16. Robert Buckland 17. Alex Burghart 18. Alistair Burt 19. Alun Cairns 20. James Cartlidge 21. Alex Chalk 22. Jo Churchill 23. Greg Clark 24. Colin Clark 25. Ken Clarke 26. James Cleverly 27. Thérèse Coffey 28. Alberto Costa 29. Glyn Davies 30. Jonathan Djanogly 31. Leo Docherty 32. Oliver Dowden 33. David Duguid 34. Alan Duncan 35. Philip Dunne 36. Michael Ellis 37. Tobias Ellwood 38. Mark Field 39. Vicky Ford 40. Kevin Foster 41. Lucy Frazer 42. George Freeman 43. Mike Freer 44. Mark Garnier 45. David Gauke 46. Nick Gibb 47. John Glen 48. Robert Goodwill 49. Michael Gove 50. Luke Graham 51. Richard Graham 52. Bill Grant 53. Helen Grant 54. Damian Green 55. Justine Greening 56. Dominic Grieve 57. Sam Gyimah 58. Kirstene Hair 59. Luke Hall 60. Philip Hammond 61. Stephen Hammond 62. Matt Hancock 63. Richard Harrington 64. Simon Hart 65. Oliver Heald 66. Peter Heaton-Jones 67. Damian Hinds 68. Simon Hoare 69. George Hollingbery 70. Kevin Hollinrake 71. Nigel Huddleston 72. Jeremy Hunt 73. Nick Hurd 74. Alister Jack (Teller) 75. Margot James 76. Sajid Javid 77. Robert Jenrick 78. Jo Johnson 79. Andrew Jones 80. Gillian Keegan 81. Seema Kennedy 82. Stephen Kerr 83. Mark Lancaster 84. -
Progress in the Development of Potential Therapeutics and Vaccines Against COVID-19 Pandemic
Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423) Volume 5 Issue 7 July 2021 Review Article Progress in the Development of Potential Therapeutics and Vaccines against COVID-19 Pandemic Abhishek Kumar Yadav, Shubham Kumar and Vikramdeep Monga* Received: May 02, 2021 Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, Published: June 09, 2021 India © All rights are reserved by Vikramdeep *Corresponding Author: Vikramdeep Monga, Department of Pharmaceutical Monga., et al. Chemistry, ISF College of Pharmacy, Moga, Punjab, India. Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 or coronavirus disease 2019 and the same has been declared as a global pandemic by WHO which marked the third introduction of a virulent coronavirus into human society. This a threat to human life worldwide. Considerable efforts have been made for developing effective and safe drugs and vaccines against is a highly pathogenic human coronavirus in which pneumonia of unknown origin was identified in China in December 2019 and is SARS-CoV-2. The current situation and progress in the development of various therapeutic candidates including vaccines in preclini- cal and clinical studies have been described in the manuscript. Until now, many people have been infected with this lethal virus, and a lot of people have died from this COVID-19. This viral disease spreads by coming in contact with an infected person. Understand- ing of SARS-CoV-2 is growing in relation to its epidemiology, virology, and clinical management strategies. Till date, very few drugs or vaccines have been developed or approved for the treatment of this deadly disease of COVID-19 and many candidates are under the clinical development pipeline. -
National Emergency Management Organisation (Nemo) Ministry of National Security St
NATIONAL EMERGENCY MANAGEMENT ORGANISATION (NEMO) MINISTRY OF NATIONAL SECURITY ST. VINCENT AND THE GRENADINES WEST INDIES Tel: 784-456-2975, Fax: 784-457-1691, Email: [email protected] or [email protected] ______________________________________________________________________________ ___________________________________________________________________________________________________________________ HEALTH SERVICES SUBCOMMITTEE PROTOCOL FOR THE ENTRY OF FULLY VACCINATED TRAVELLERS TO ST. VINCENT AND THE GRENADINES – revised 10/08/2021 AIM: The safe entry of travellers to St. Vincent and the Grenadines in a manner that reduces the risk of the importation and subsequent transmission of COVID-19 in St. Vincent and the Grenadines. OBJECTIVES: 1. To establish the risk of the arriving traveller introducing new COVID-19 cases to SVG; 2. To minimize exposure of residents of SVG to new COVID-19 cases; 3. Early identification of potential exposure to COVID-19 and 4. Early containment of new COVID-19 cases. ESTABLISH RISK OF ARRIVING TRAVELLER: The arriving traveller will: 1. Complete the Pre-Arrival Form available at health.gov.vc And the Port Health Officer will: 1. Review Port Health form for each arriving passenger. 1 PHASED PROCESS OF ENTRY OF FULLY VACCINATED TRAVELERS TO ST. VINCENT AND THE GRENADINES: TESTING & QUARANTINE: PHASE #16 - Commencing Wednesday, August 11, 2021: 1. Where ‘Fully Vaccinated Travelers’ are those persons who: a. Have completed a vaccination regimen with one of the following COVID-19 vaccines recognized by the Ministry of Health, Wellness and the Environment of St Vincent and the Grenadines: i. AstraZeneca – Oxford AstraZeneca (Vaxzevria), COVISHIELD, AstraZeneca COVID-19 vaccine by SK Bioscience; ii. Pfizer-BioNTech COVID-19 vaccine; iii. Moderna COVID-19 vaccine; iv.